About Human Follicle-Stimulating Hormone Receptor (FSHR) Stable Cell Line

Follicle-Stimulating Hormone Receptor (FSHR) is a Class A G protein-coupled receptor (GPCR) that serves as the primary receptor for follicle-stimulating hormone (FSH), a glycoprotein hormone produced by the anterior pituitary gland. FSHR is predominantly expressed in ovarian granulosa cells in females and Sertoli cells in the testes of males, where it plays essential roles in reproductive development, gametogenesis, and endocrine regulation. Upon binding FSH, FSHR primarily couples to Gs proteins, stimulating adenylate cyclase activity and increasing intracellular cAMP levels, which subsequently activate downstream signaling pathways involved in cell proliferation, differentiation, steroidogenesis, and reproductive function.

FSHR is a critical regulator of follicular development, estrogen production, ovulation, spermatogenesis, and fertility. In women, FSHR signaling promotes ovarian follicle maturation and estrogen synthesis, while in men it supports Sertoli cell function and sperm production. Dysregulation of FSHR signaling has been associated with infertility, ovarian dysfunction, polycystic ovary syndrome (PCOS), premature ovarian insufficiency, and other reproductive disorders. Because of its central role in reproductive biology and assisted reproductive technologies (ART), FSHR has become an important therapeutic target and a major focus of reproductive medicine and drug discovery research.

eEnzyme's Human FSHR Stable Cell Line provides a reliable and reproducible cellular platform for investigating FSHR-mediated signaling pathways and evaluating receptor-targeted therapeutics. The cell line enables quantitative assessment of agonists, antagonists, biosimilars, and allosteric modulators through cAMP assays, reporter gene assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, potency determination, lead optimization, biosimilar comparability studies, and high-throughput screening applications supporting reproductive health and fertility research.

Applications of the FSHR Stable Cell Line

• FSH receptor pharmacology studies
• Agonist and antagonist screening
• Fertility and reproductive biology research
• Assisted reproductive technology (ART) development
• Biosimilar and biologic potency testing
• cAMP and GPCR signaling assays
• Steroidogenesis and follicular development studies
• High-throughput screening applications

Biological Significance of FSHR

FSHR is a master regulator of reproductive function and gonadal development. Activation of FSHR stimulates cAMP-dependent signaling pathways that promote ovarian follicle growth, estrogen biosynthesis, granulosa cell differentiation, and ovulation in females, while supporting Sertoli cell function and spermatogenesis in males. Because FSHR signaling directly influences fertility and reproductive health, the receptor is widely studied in reproductive endocrinology, infertility treatment, and hormone therapy development. In addition, emerging evidence suggests that FSHR expression may occur in certain tumors and tumor-associated vasculature, creating additional opportunities for therapeutic research. Due to its essential physiological functions and clinical relevance, FSHR remains one of the most important GPCR targets in reproductive medicine, endocrinology, and fertility-focused drug discovery programs. The FSHR Stable Cell Line provides a valuable tool for studying receptor biology and advancing the development of next-generation reproductive therapeutics.